Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 68.82M | 59.06M | 63.43M | 76.38M | 78.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.82M | 59.06M | 63.43M | 76.38M | 78.47M |
| Cost of Revenue | 54.17M | 46.23M | 50.36M | 57.98M | 61.37M |
| Gross Profit | 14.65M | 12.83M | 13.07M | 18.41M | 17.10M |
| SG&A Expenses | 8.02M | 7.97M | 8.58M | 9.77M | 8.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 639.00K | -- | -- |
| Total Operating Expenses | 64.02M | 55.84M | 61.26M | 69.57M | 71.69M |
| Operating Income | 4.81M | 3.22M | 2.17M | 6.81M | 6.78M |
| Income Before Tax | 3.97M | 2.51M | 1.98M | 5.69M | 5.70M |
| Income Tax Expenses | 576.00K | 657.00K | 60.00K | 1.32M | 1.18M |
| Earnings from Continuing Operations | 3.39M | 1.86M | 1.92M | 4.37M | 4.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.39M | 1.86M | 1.92M | 4.37M | 4.52M |
| EBIT | 4.81M | 3.22M | 2.17M | 6.81M | 6.78M |
| EBITDA | 6.50M | 5.15M | 3.46M | 8.87M | 8.82M |
| EPS Basic | 0.27 | 0.15 | 0.15 | 0.35 | 0.35 |
| Normalized Basic EPS | 0.20 | 0.13 | 0.10 | 0.29 | 0.28 |
| EPS Diluted | 0.26 | 0.14 | 0.14 | 0.32 | 0.33 |
| Normalized Diluted EPS | 0.19 | 0.12 | 0.10 | 0.26 | 0.26 |
| Average Basic Shares Outstanding | 12.57M | 12.37M | 12.78M | 12.49M | 12.90M |
| Average Diluted Shares Outstanding | 13.05M | 13.25M | 12.96M | 13.66M | 13.68M |
| Dividend Per Share | -- | -- | 0.16 | -- | -- |
| Payout Ratio | 60.70% | -- | 0.00% | -- | 44.18% |